Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Epilepsy × Midazolam × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Liposarcoma 1 Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery 1 Epilepsy 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma of Lung 1

Interventions

Midazolam 1 LY3295668 erbumine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03955939 2020-06-01

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Eli Lilly and Company

Phase 1 Completed

Breast Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡